Related Experiment Video
Updated: Dec 26, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.8K
Type 2 Diabetic Patients Adherence Towards Their Medications
Khalid A Alshehri1, Talal M Altuwaylie1, Ali Alqhtani1
1Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Cureus
|March 20, 2020
Summary
Most type 2 diabetes mellitus patients in Saudi Arabia adhere to medication, but forgetting is a key issue. Improving adherence is vital for better health outcomes and quality of life.
Area of Science:
- Endocrinology
- Public Health
- Pharmaceutical Sciences
Background:
- Type 2 diabetes mellitus (T2DM) is a prevalent noncommunicable disease impacting quality of life, necessitating effective treatment adherence.
- Unhealthy lifestyle factors like poor diet and inactivity are primary T2DM contributors, often requiring pharmacological intervention.
- Limited research exists on T2DM treatment adherence within Saudi Arabia.
Purpose of the Study:
- To assess medication adherence rates among T2DM patients in Jeddah, Saudi Arabia.
- To identify common barriers to treatment adherence in this population.
- To inform strategies for improving T2DM management and patient outcomes.
Main Methods:
- A cross-sectional analytical study was conducted.
- 387 T2DM patients from three primary health care centers in Jeddah participated.
- Data were collected via self-completed questionnaires after obtaining informed consent.
Main Results:
- A majority of patients (68.5%) reported adherence to their T2DM medications.
- A significant portion (31.5%) were nonadherent, with forgetting medication being the most frequent reason.
- Nonadherence was linked to poorer health outcomes and reduced quality of life.
Conclusions:
- While medication adherence is relatively high, forgetting poses a significant challenge for T2DM patients in Saudi Arabia.
- Targeted interventions and awareness campaigns are crucial to address nonadherence.
- Reducing nonadherence can mitigate T2DM complications and lessen the disease burden.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
785
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
785
01:36Carbohydrate Metabolism
13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:16Insulin: Dosing Regimen and Adverse Effects
581
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
581
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K